A detailed history of National Bank Of Canada transactions in Scynexis Inc stock. As of the latest transaction made, National Bank Of Canada holds 20,000 shares of SCYX stock, worth $18,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,000
Previous 8,000 150.0%
Holding current value
$18,000
Previous $11,000 109.09%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$1.0 - $1.53 $12,000 - $18,360
12,000 Added 150.0%
20,000 $23,000
Q3 2024

Nov 12, 2024

SELL
$1.27 - $2.23 $2,540 - $4,460
-2,000 Reduced 20.0%
8,000 $11,000
Q2 2024

Aug 02, 2024

BUY
$1.4 - $2.77 $14,000 - $27,700
10,000 New
10,000 $20,000
Q1 2023

Apr 12, 2023

BUY
$1.15 - $3.0 $216 - $564
188 New
188 $0

Others Institutions Holding SCYX

About SCYNEXIS INC


  • Ticker SCYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 32,651,800
  • Market Cap $29.4M
  • Description
  • SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...
More about SCYX
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.